Federation des caisses Desjardins du Quebec’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Buy |
31,475
+7,200
| +30% | +$471K | 0.01% | 653 |
|
|
2025
Q1 | $1.63M | Buy |
24,275
+3,225
| +15% | +$216K | 0.01% | 680 |
|
|
2024
Q4 | $1.16M | Buy |
21,050
+1,500
| +8% | +$82.8K | 0.01% | 762 |
|
|
2024
Q3 | $1.17M | Hold |
19,550
| – | – | 0.01% | 749 |
|
|
2024
Q2 | $1.24M | Sell |
19,550
-1,600
| -8% | -$102K | 0.01% | 699 |
|
|
2024
Q1 | $1.17M | Hold |
21,150
| – | – | 0.01% | 675 |
|
|
2023
Q4 | $1.17M | Hold |
21,150
| – | – | 0.01% | 580 |
|
|
2023
Q3 | $1.23M | Buy |
21,150
+3,200
| +18% | +$186K | 0.01% | 526 |
|
|
2023
Q2 | $966K | Hold |
17,950
| – | – | 0.01% | 615 |
|
|
2023
Q1 | $713K | Buy |
+17,950
| New | +$713K | 0.01% | 677 |
|
|
2022
Q4 | – | Sell |
-17,800
| Closed | -$572K | – | 2483 |
|
|
2022
Q3 | $572K | Buy |
17,800
+1,800
| +11% | +$57.9K | 0.01% | 734 |
|
|
2022
Q2 | $475K | Hold |
16,000
| – | – | 0.01% | 804 |
|
|
2022
Q1 | $450K | Hold |
16,000
| – | – | ﹤0.01% | 874 |
|
|
2021
Q4 | $737K | Buy |
16,000
+10,849
| +211% | +$500K | 0.01% | 746 |
|
|
2021
Q3 | $169K | Buy |
+5,151
| New | +$169K | ﹤0.01% | 1216 |
|
|
2020
Q4 | – | Sell |
-38,850
| Closed | -$1.1M | – | 2325 |
|
|
2020
Q3 | $1.1M | Hold |
38,850
| – | – | 0.02% | 540 |
|
|
2020
Q2 | $1.26M | Buy |
38,850
+4,150
| +12% | +$135K | 0.02% | 490 |
|
|
2020
Q1 | $1.43M | Buy |
34,700
+15,700
| +83% | +$647K | 0.02% | 431 |
|
|
2019
Q4 | $1.17M | Buy |
19,000
+3,000
| +19% | +$185K | 0.02% | 614 |
|
|
2019
Q3 | $1.17M | Hold |
16,000
| – | – | 0.02% | 601 |
|
|
2019
Q2 | $1.31M | Buy |
16,000
+9,017
| +129% | +$740K | 0.02% | 555 |
|
|
2019
Q1 | $492K | Buy |
+6,983
| New | +$492K | 0.01% | 743 |
|